Increased androgen levels can induce vasoconstriction and endothelial dysfunction by decreasing NO bioavailability and enhancing oxidative stress via upregulation of NADPH oxidase, which increases ROS production [120]. The gene discussed is FMO5; the disease is endothelial dysfunction.